27 more hESC lines head for OK

Twenty-seven human embryonic stem cell (hESC) lines are ethically derived and should be approved for use in research funded by the US linkurl:National Institutes of Health;http://www.nih.gov/ (NIH), a committee advising the NIH director linkurl:recommended today (December 4).;http://acd.od.nih.gov/agendas/Tab-1-Agenda-FINAL.pdf These findings come just two days after the approval of the first 13 lines linkurl:earlier this week.;http://www.the-scientist.com/blog/display/56196/ Human embryonic st

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Twenty-seven human embryonic stem cell (hESC) lines are ethically derived and should be approved for use in research funded by the US linkurl:National Institutes of Health;http://www.nih.gov/ (NIH), a committee advising the NIH director linkurl:recommended today (December 4).;http://acd.od.nih.gov/agendas/Tab-1-Agenda-FINAL.pdf These findings come just two days after the approval of the first 13 lines linkurl:earlier this week.;http://www.the-scientist.com/blog/display/56196/
Human embryonic stem cells
Image: Wikimedia commons,
Nissim Benvenisty
There was one provision, though: The funding must be limited to projects that follow the precise wording in the consent forms, which states the embryos will be used for research on embryonic development of endoderm with a focus on pancreatic beta cell formation. The 27 lines were all part of a single submission from Harvard University, where researchers have been using them for a variety of projects. The Harvard IRB had determined the cells could be used more broadly than stated in the consent forms. A 28th line from the same submission was not recommended for NIH approval because the consent was received during a lapse in Harvard's IRB. The review of the Harvard lines raises an issue that's likely to come up again: how to determine whether submitted lines should be approved only for research specified in the consent forms, or for broader use. The committee asked the NIH to prepare guidelines addressing this issue for future decisions.
**__Related stories:__***linkurl: NIH OKs 13 stem cell lines;http://www.the-scientist.com/blog/display/56196/
[2nd December 2009]*linkurl:NIH picks stem cell panel;http://www.the-scientist.com/blog/display/55991/
[21st September 2009]*linkurl:Two stem cell lines lead studies;http://www.the-scientist.com/blog/display/55885/
[12th August 2009]*linkurl:NIH loosens stem cell consent rules;http://www.the-scientist.com/blog/display/55814/
[6th July 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems